Subtype-selective prenylated isoflavonoids disrupt regulatory drivers of MYCN-amplified cancers

Stokes, M. E., Vasciaveo, A., Small, J. C., Zask, A., Reznik, E., Smith, N., Wang, Q., Daniels, J., Forouhar, F., Rajbhandari, P., Califano, A., & Stockwell, B. R. (2024). Subtype-selective prenylated isoflavonoids disrupt regulatory drivers of MYCN-amplified cancers. Cell Chemical Biology, 31(4), 805-819.e9. https://doi.org/10.1016/j.chembiol.2023.11.007
Authors:
Michael E Stokes
Alessandro Vasciaveo
Jonnell Candice Small
Arie Zask
Eduard Reznik
Nailah Smith
Qian Wang
Jacob Daniels
Farhad Forouhar
Presha Rajbhandari
Andrea Califano
Brent R Stockwell
Affiliated Authors:
Michael E Stokes
Alessandro Vasciaveo
Jonnell Candice Small
Arie Zask
Eduard Reznik
Nailah Smith
Qian Wang
Jacob Daniels
Farhad Forouhar
Presha Rajbhandari
Andrea Califano
Brent R Stockwell
Subjects:
Author Keywords:
casein kinase 2
ck2
drug discovery
isoflavonoid
isopomiferin
mycn
neuroblastoma
plateseq
pomiferin
viper
Publication Type:
Article
Unique ID:
10.1016/j.chembiol.2023.11.007
PMID:
Publication Date:
Data Source:
PubMed

Record Created: